February is National Heart Month. Atrial fibrillation is a common condition in older demographics, but what is A-Fib? In this segment, Dr. Rudy Evanich from Bellin Health discusses what to ...

Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.

MONTREAL and CHARLOTTE, N.C., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of ...

Etripamil for patients with atrial fibrillation with rapid ventricular rate (AFib-RVR) Phase 3 pivotal trial ... Important factors that could cause actual results to differ materially from those ...

PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)- Commercial capabilities ...

Etripamil for patients with atrial fibrillation with rapid ventricular rate (AFib-RVR) Phase 3 pivotal trial ... Important factors that could cause actual results to differ materially from those ...

Three RVR Bank title changes were announced at the recent RVR Bank annual meeting. Tessie Collins was promoted to marketing coordinator, Ashley Kult to retail banking specialist — loan officer ...

Phase 3 pivotal trial in AFib-RVR expected to begin enrollment in H1 2025 ... Important factors that could cause actual results to differ materially from those in the forward-looking statements ...

The annual wellness visit is beneficial for patients, providers, and payers with an emphasis on preventive care for early intervention. Today, we're diving deep into a crucial aspect of preventive ...